Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Faulding launches wound care line in Australia and New Zealand

April 15, 1997

Merck & Co. prepares cytokine inhibitors

April 15, 1997

Scherer granted U.S. patent for ascorbic acid in softgel delivery system

April 14, 1997

Connetics commences phase III trial for betamethasone mousse

April 8, 1997

Human skin equivalent approved in Canada

April 8, 1997

Clinical efficacy and safety of Aphthasol reviewed

April 7, 1997

ProCyte reports results from hair growth trial

April 7, 1997

Pharmadigm's PB-OO5 enters phase II as burn treatment

April 2, 1997

ICOS initiates phase I with monoclonal antibody

April 1, 1997

Antiinflammatory compounds disclosed by Tsumura

April 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...